The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Genfit SA(NASDAQ:GNFT) 
Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, autoimmune, and fibrotic diseases affecting primarily the liver and gastroenterology. The company's lead products include Elafibranor, which is in pivotal Phase III clinical trials for ...
Website: http://www.genfit.com
Founded: 1999
Full Time Employees: 203
CEO: Pascal Prigent
Sector: Healthcare
Industry: Biotechnology
Genfit SA Days Payable Outstanding ttm (DPO)
Genfit SA Days Receivable Outstanding ttm (DSO)
Genfit SA Days Inventory Outstanding ttm (DIO)
Genfit SA Op Cashflow Per Share ttm
Genfit SA Free Cashflow Per Share ttm
Genfit SA Cash Per Share ttm
Genfit SA P/S ratio ttm
Genfit SA (GAAP) P/E ratio ttm
Genfit SA P/B ratio ttm
No extra charts and metrics for this ticker.